For Q2FY24, Granules India’s revenue grew by 3.4% YoY and 20.7% QoQ to INR 11,895 Mn, while for H1FY24 revenue grew marginally by 0.2% YoY to INR 21,750 Mn. Volume growth in the quarter was higher than value growth. Active Pharmaceuticals Ingredients (API), Pharmaceutical Formulation Intermediates (PFI), and Finished dosages (FD) contributed 25.4%, 12.2%, and 62.4% of revenue from operations, respectively.